HT
MRNA icon

HAP Trading’s Moderna MRNA Stock Holding History

HAP Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,736
Closed -$1.49M – 936
2023
Q4 		$1.47M Sell
14,736
-9,384
-39% -$789K 0.23% 95
2023
Q3 		$2.49M Buy
+24,120
New +$2.69M 0.4% 57
2022
Q2 		– Sell
-13,611
Closed -$1.95M – 2217
2022
Q1 		$2.35M Buy
13,611
+3,564
+35% +$600K 0.1% 186
2021
Q4 		$2.55M Sell
10,047
-14,444
-59% -$4.22M 0.07% 254
2021
Q3 		$9.43M Sell
24,491
-19,884
-45% -$7.33M 0.31% 67
2021
Q2 		$10.4M Buy
44,375
+29,400
+196% +$5.25M 0.33% 61
2021
Q1 		$1.96M Buy
+14,975
New +$2.17M 0.11% 182
2020
Q2 		– Sell
-23,948
Closed -$1.31M – 1837
2020
Q1 		$717K Buy
+23,948
New +$551K 0.05% 282
2019
Q4 		– Sell
-18,800
Closed -$299K – 1386
2019
Q3 		$299K Buy
+18,800
New +$278K 0.02% 418

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HAP Trading's MRNA Position: Q1 2024 in Review

HAP Trading sold out of Moderna (MRNA) in Q1 2024, closing a stake of 14,736 shares — an estimated $1.49M sold.

HAP Trading first reported a position in MRNA in Q3 2019 and held it in 9 quarters. The position peaked at $10.4M in Q2 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • HAP Trading reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • HAP Trading sold 14,736 Moderna shares in Q1 2024, an estimated $1.49M.
  • HAP Trading first reported a position in Moderna in Q3 2019 and held it in 9 quarters.
  • HAP Trading's Moderna position peaked at $10.4M in Q2 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on HAP Trading's 13F filing for Q1 2024, filed 13 May 2024.